Unexpected Protective Role of Thrombosis in Lung Injury via Endothelial Alox15.

Summary

In murine sepsis models, mild pulmonary thrombosis paradoxically reduced endothelial apoptosis, lung injury, and mortality via sustained endothelial ALOX15 expression. Endothelial-targeted gene modulation and lipidomic rescue experiments identify ALOX15 and its lipid mediators as therapeutic candidates for inflammatory lung injury.

Key Findings

• Mild pulmonary thrombosis reduced endothelial apoptosis, ALI severity, and mortality in sepsis models via sustained endothelial ALOX15 expression.
• Endothelial-specific CRISPR knockout or overexpression of Alox15 modulated lung injury; lipidomics identified ALOX15-regulated lipids mediating protection.
• Severe thrombosis or thrombocytopenia worsened ALI, offering a mechanistic explanation for failed anticoagulant trials in sepsis/ARDS.

Clinical Implications

Cautious anticoagulation strategies may be warranted in ARDS (acute respiratory distress syndrome), as moderate thrombosis could be protective via endothelial ALOX15. Therapeutic upregulation of ALOX15 or administration of its protective lipid mediators merits translational investigation.

Limitations

• Preclinical murine models may not fully translate to human ARDS and sepsis.
• Safety and feasibility of modulating thrombosis or delivering ALOX15-targeted therapies in humans are unknown.

Future Directions

Validate the ALOX15–lipid mediator axis in large-animal models and human biospecimens; develop pharmacologic or gene-based strategies to upregulate ALOX15 without prothrombotic risk; stratify ARDS patients by thrombosis burden and endothelial phenotype.